199 related articles for article (PubMed ID: 7476237)
1. Personal experience with diagnostic and therapeutic aspects of human Leishmania (Viannia) braziliensis in Três Braços.
Marsden PD
Mem Inst Oswaldo Cruz; 1994; 89(3):485-7. PubMed ID: 7476237
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of patients with Leishmania (Viannia) braziliensis infection and treated with Glucantime.
Netto EM; Marsden PD; Llanos-Cuentas EA; Costa JM; Cuba CC; Barreto AC; Badaró R; Johnson WD; Jones TC
Trans R Soc Trop Med Hyg; 1990; 84(3):367-70. PubMed ID: 2260171
[TBL] [Abstract][Full Text] [Related]
3. American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis resistant to meglumine antimoniate, but with good response to pentamidine: a case report.
Pimentel MI; Baptista C; Rubin EF; Vasconcellos Ede C; Lyra MR; Salgueiro Mde M; Saheki MN; Rosalino CM; Madeira Mde F; Silva AF; Confort EM; Schubach Ade O
Rev Soc Bras Med Trop; 2011; 44(2):254-6. PubMed ID: 21552747
[TBL] [Abstract][Full Text] [Related]
4. Disseminated cutaneous leishmaniasis caused by Leishmania braziliensis in Southern Brazil.
Membrive NA; Kazuma FJ; Silveira TGV; Teixeira JJV; Reinhold-Castro KR; Teodoro U
Rev Inst Med Trop Sao Paulo; 2017 Jun; 59():e37. PubMed ID: 28591265
[TBL] [Abstract][Full Text] [Related]
5. Effective meglumine antimoniate intralesional therapy for Chiclero's ulcer refractory to systemic liposomal amphotericin B.
Spinicci M; Zammarchi L; Gramiccia M; Di Muccio T; Bartolozzi D; Corsi P; Trotta M; Bartoloni A
J Travel Med; 2021 Aug; 28(6):. PubMed ID: 32918547
[No Abstract] [Full Text] [Related]
6. Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate.
Romero GA; Guerra MV; Paes MG; Macêdo VO
Am J Trop Med Hyg; 2001 Nov; 65(5):456-65. PubMed ID: 11716098
[TBL] [Abstract][Full Text] [Related]
7. The activity of azithromycin against Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis in the golden hamster model.
Sinagra A; Luna C; Abraham D; Iannella Mdel C; Riarte A; Krolewiecki AJ
Rev Soc Bras Med Trop; 2007; 40(6):627-30. PubMed ID: 18200413
[TBL] [Abstract][Full Text] [Related]
8. Treatment of imported New World cutaneous leishmaniasis in Germany.
Harms G; Scherbaum H; Reiter-Owona I; Stich A; Richter J
Int J Dermatol; 2011 Nov; 50(11):1336-1342. PubMed ID: 22004484
[TBL] [Abstract][Full Text] [Related]
9. A randomized clinical trial comparing meglumine antimoniate, pentamidine and amphotericin B for the treatment of cutaneous leishmaniasis by Leishmania guyanensis.
Neves LO; Talhari AC; Gadelha EP; Silva Júnior RM; Guerra JA; Ferreira LC; Talhari S
An Bras Dermatol; 2011; 86(6):1092-101. PubMed ID: 22281895
[TBL] [Abstract][Full Text] [Related]
10. Responses of Leishmania (Viannia) braziliensis cutaneous infection to N-methylglucamine antimoniate in the rhesus monkey (Macaca mulatta) model.
Teva A; Porrozzi R; Oliveira-Neto MP; Grimaldi GJ
J Parasitol; 2005 Aug; 91(4):976-8. PubMed ID: 17089782
[TBL] [Abstract][Full Text] [Related]
11. Genotypic profiles of Leishmania (Viannia) braziliensis strains from cutaneous leishmaniasis patients and their relationship with the response to meglumine antimoniate treatment: a pilot study.
Gagini T; de Oliveira Schubach A; de Fatima Madeira M; Maria Valete-Rosalino C; Fernandes Pimentel MI; da Silva Pacheco R
Parasite; 2017; 24():34. PubMed ID: 28959938
[TBL] [Abstract][Full Text] [Related]
12. [American tegumentary leishmaniasis caused by Leishmania (Viannia) braziliensis in military training area of Zona da Mata in Pernambuco].
Andrade MS; Brito ME; Silva ST; Lima BS; Almeida EL; Albuquerque EL; Marinho Júnior JF; Ishikawa E; Cupolillo E; Brandão-Filho SP
Rev Soc Bras Med Trop; 2005; 38(3):229-33. PubMed ID: 15895173
[TBL] [Abstract][Full Text] [Related]
13. Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil.
Romero GA; de la Glória Orge Orge M; de Farias Guerra MV; Paes MG; de Oliveira Macêdo V; de Carvalho EM
Acta Trop; 2005 Jan; 93(1):49-56. PubMed ID: 15589797
[TBL] [Abstract][Full Text] [Related]
14. Low dose glucantime therapy in Leishmania viannia braziliensis (Lvb) infections.
Costa JM; Marsden PD
Rev Soc Bras Med Trop; 1988; 21(2):85-6. PubMed ID: 3249826
[No Abstract] [Full Text] [Related]
15. [Slowly progressing skin ulcers following a stay in Costa Rica].
Mateo M; Cruz I; Flores MD; López-Vélez R
Enferm Infecc Microbiol Clin; 2005 Apr; 23(4):243-4. PubMed ID: 15826551
[No Abstract] [Full Text] [Related]
16. [A comparative study between sodium stibogluconate BP 88R and meglumine antimoniate in the treatment of cutaneous leishmaniasis. I. The efficacy and safety].
Saldanha AC; Romero GA; Merchan-Hamann E; Magalhães AV; Macedo Vde O
Rev Soc Bras Med Trop; 1999; 32(4):383-7. PubMed ID: 10495667
[TBL] [Abstract][Full Text] [Related]
17. Early enlargement of an ulcerated area during leishmaniasis treatment with meglumine antimoniate in Brazil.
Romero GA; Molinet FJ; Noronha EF
Trans R Soc Trop Med Hyg; 2013 Apr; 107(4):266-8. PubMed ID: 23315614
[TBL] [Abstract][Full Text] [Related]
18. Visceral leishmaniasis with cutaneous and rectal dissemination due to Leishmania braziliensis in acquired immunodeficiency syndrome (AIDS).
Hernández DE; Oliver M; Martínez C; Planas G
Int J Dermatol; 1995 Feb; 34(2):114-5. PubMed ID: 7737768
[No Abstract] [Full Text] [Related]
19. Atypical manifestations of tegumentary leishmaniasis in a transmission area of Leishmania braziliensis in the state of Bahia, Brazil.
Guimarães LH; Machado PR; Lago EL; Morgan DJ; Schriefer A; Bacellar O; Carvalho EM
Trans R Soc Trop Med Hyg; 2009 Jul; 103(7):712-5. PubMed ID: 19481233
[TBL] [Abstract][Full Text] [Related]
20. Disseminated cutaneous leishmaniasis: ulcerovegetative and ulcero-crusted lesions.
Sgarbi IM; Santos FD; Monteiro VE; Fonseca SN; Bernardes Filho F
Braz J Infect Dis; 2017; 21(2):201-202. PubMed ID: 28012931
[No Abstract] [Full Text] [Related]
[Next] [New Search]
